Database updated: 14 June 2026
Safety Information
Medsafe Online Recall Database
Detail of Recall
| Type of Product: | Medicine |
| Medsafe Reference: | 36679 |
| Brand Name: | Eqalis CBD30 |
| Dose Form/Strength: | Oral solution 30 mg/mL |
| Affected: | |
| Recalling Organisation: | Eqalis Pharmaceuticals Limited |
| Contact Information: | |
| Manufacturer: | Eqalis Pharmaceuticals Limited |
| Issue: | Dithiocarbamates (CS2) were detected in two batches of Eqalis-manufactured full-spectrum dosage products, exceeding the OOS limit of <2 mg/kg. |
| Recall action type: | Recall - Unapproved medicine |
| Recall action: | Recall |
| Level of recall: | Hospital/Pharmacy/Laboratory |
| Date Commenced: | 28/5/2026 |
